At GenSearch, we were proud to co-host the recent HealthTech Dinner in Basel with PwC Switzerland, bringing together senior leaders from across Pharma and Life Sciences to discuss the shift from product-led to patient- and consumer-centric models.
Read more “๐๐ฟ๐ผ๐บ ๐ฝ๐ฟ๐ฒ๐๐ฐ๐ฟ๐ถ๐ฝ๐๐ถ๐ผ๐ป๐ ๐๐ผ ๐ฝ๐ฒ๐ผ๐ฝ๐น๐ฒ โ ๐ฟ๐ฒ๐ณ๐น๐ฒ๐ฐ๐๐ถ๐ผ๐ป๐ ๐ณ๐ฟ๐ผ๐บ ๐๐ฎ๐๐ฒ๐น”
Unlocking Private Equity: What It Really Takes to Lead in a PE-Backed Company
In this session, our expert speakers shared insights into the realities of leadership in private equity-backed companies, what demands, what often goes unsaid, and how to thrive in this high-performance environment.
ย Read more “Unlocking Private Equity: What It Really Takes to Lead in a PE-Backed Company”
GenSearch Earns EcoVadis Gold Medal Again for Sustainability Excellence in Life Sciences Executive Search
Weโre proud to announce that GenSearch, a leading executive search firm specialised in the life sciences sector, has once again been awarded the prestigious EcoVadis Gold Medal. This award recognises GenSearch for Sustainability Excellence in Life Sciences Executive Search, placing us in the top 5% of companies worldwide for our sustainability performanceโa testament to our consistent commitment to Environmental, Social, and Governance (ESG) principles.
GenSearch Signs the French Charte de la Diversitรฉ
Supporting Diversity in Life Sciences Recruitment
GenSearch has signed the Charte de la Diversitรฉ, a national charter in France that encourages organisations to take practical action against discrimination and promote inclusion across all areas of employment. This commitment reflects our intention to build fairer recruitment processes and contribute to more representative leadership in the life sciences sector.
What Is the Charte de la Diversitรฉ?
Launched in 2004, the Charte de la Diversitรฉ brings together organisations that voluntarily commit to advancing diversity in the workplace. Signatories work to ensure:
- Awareness and training on diversity and inclusion
- Equal opportunities during recruitment and career progression
- Representation of societal diversity within their teams
- Transparent evaluation and accountability mechanisms
Over 5,000 companies in France have signed the Charter to date, spanning a wide range of industries and sectors.
Why This Matters for Executive Search
In executive search for the life sciences industry, inclusive hiring is essential. Signing the Charte de la Diversitรฉ strengthens GenSearchโs alignment with best practices in:
- Fair and unbiased recruitment: Ensuring all candidates are evaluated on skills, experience, and potential โ not personal background
- Inclusive leadership advisory: Helping clients build diverse executive teams that reflect their markets and stakeholders
- Internal workplace equity: Promoting respect, safety, and opportunity within our own teams
Diversity in leadership leads to more robust decision-making, increased innovation, and stronger organisational performance โ all critical factors in healthcare and science.
HealthTech Dinner Paris 2024 โ What Role for Start-up Studios?
Our 10th Parisian HealthTech Dinner took place on Tuesday 9th July 2024 and despite the competition from the France โ Spain match, the room was full yet again!
Everyone had a wonderful evening in Paris, with our 3 speakers Pierre-Albert Colcomb from Ampleia, Clรฉment Bertholet from AdBio partners and Stephane Tholander from Agora Health.

GenSearch and Signal Hill Partners Announce Strategic Partnership to Enhance Retained Executive Search
Paris, France 2nd October 2023 โ GenSearch in Europe and Signal Hill Partners in the United States are thrilled to announce a strategic partnership aimed at expanding their international reach and strengthening their position as leading providers of executive search focused on the life sciences to better serve their clients both sides of the Atlantic.
Read more “GenSearch and Signal Hill Partners Announce Strategic Partnership to Enhance Retained Executive Search”Season’s Greetings 2023
Bio-Europe 2022 Leipzig

Meet us at Bio Europe 2022ย to digitally bring together the life science community for global dealmaking.
Read more “Bio-Europe 2022 Leipzig”12th ANNUAL EUROPEAN LIFE SCIENCES CEO FORUM
Back for its 12th Annual edition, this global bio-pharma industry forum addresses through its conference programme the main challenges for 2019 in investment, partnering and alliance management. Read more “12th ANNUAL EUROPEAN LIFE SCIENCES CEO FORUM”
White Paper – The Future of Healthcare: when ‘care=cure’
THE NEXT TRANSFORMATION IN HEALTHCARE
Read more “White Paper – The Future of Healthcare: when ‘care=cure’”

